U.S. Water Utilities Stock News

NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

SoFi Technologies Q3 Net Margin Expansion Reinforces Bullish Profitability Narratives

SoFi Technologies FY 2025 earnings snapshot SoFi Technologies (SOFI) has put up another solid set of numbers for FY 2025 so far, with Q3 revenue at US$952.4 million and basic EPS of US$0.12, backed by trailing twelve month net income of US$640.2 million and EPS of US$0.57. The company has seen revenue move from US$586.9 million in Q2 2024 to US$952.4 million in Q3 2025, while quarterly basic EPS has gone from US$0.01 to US$0.12 over the same stretch. This sets the stage for investors to focus...
NasdaqGS:TBBK
NasdaqGS:TBBKBanks

Is Bancorp (TBBK) Still Attractive After Recent Pullback And Strong Multi Year Rally

If you are wondering whether Bancorp at around US$59.44 is still good value after a strong multi year run, you are not alone. The stock has seen a 12.1% decline year to date, with shorter term moves of 11.5% over 7 days and 12.0% over 30 days, set against a 66.4% return over 3 years and 224.1% over 5 years. Recent news coverage has focused on Bancorp's position within the US banking sector and how investors are reassessing risk and growth expectations for regional financial institutions...
NasdaqGS:QDEL
NasdaqGS:QDELMedical Equipment

QuidelOrtho Faces Profitability Pressures Yet Trades At Steep Valuation Discount

QuidelOrtho (NasdaqGS:QDEL) is reporting declining revenues alongside falling free cash flow margins. The company is also seeing a significant drop in return on invested capital, pointing to weaker returns on recent investments. These shifts may reflect rising competitive pressures or market saturation in its core diagnostics markets. QuidelOrtho, a diagnostics company listed on the NasdaqGS under ticker QDEL, operates across lab, point of care, and transfusion medicine testing. The current...
NasdaqGS:WTW
NasdaqGS:WTWInsurance

Is It Time To Reassess Willis Towers Watson (WTW) After Recent Share Price Weakness

If you are trying to work out whether Willis Towers Watson is reasonably priced or not, starting with a clear view of its current valuation can help you decide how it fits into your portfolio. The stock last closed at US$317.47, with returns of a 1.7% decline over 7 days, a 3.4% decline over 30 days, a 2.7% decline year to date and a 2.6% decline over 1 year. The 3 year and 5 year returns sit at 30.7% and 51.4% respectively. Recent headlines around Willis Towers Watson have focused on its...
NYSE:PFSI
NYSE:PFSIDiversified Financial

PennyMac Financial Services (PFSI) Net Margin Expansion Reinforces Bullish Profitability Narratives

PennyMac Financial Services (PFSI) has wrapped up FY 2025 with fourth quarter revenue of US$538.0 million, basic EPS of US$2.05 and net income of US$106.8 million, while the trailing twelve months show total revenue of US$2.0 billion, basic EPS of US$9.69 and net income of US$501.1 million against last year’s net margin of 15.4% and earnings growth of 60.9%. Over the past few quarters, revenue has ranged from US$690.8 million to US$1.0 billion with quarterly basic EPS between US$1.48 and...
NYSE:APD
NYSE:APDChemicals

Is It Time To Reassess Air Products And Chemicals (APD) After Recent Share Price Rebound

If you are wondering whether Air Products and Chemicals is genuinely attractive at its current price, you are not alone. Many investors are asking if the stock still offers value after recent moves. The share price closed at US$272.50, with returns of 4.3% over the last week, 10.3% over the last month, 8.8% year to date, a 16.6% decline over the past year, 3.3% gains over three years and 21.8% gains over five years. Recent coverage around Air Products and Chemicals has focused on its...
NasdaqGS:ASND
NasdaqGS:ASNDBiotechs

Is It Too Late To Consider Ascendis Pharma (ASND) After A 73% One Year Surge?

If you are wondering whether Ascendis Pharma's share price still makes sense after a strong run, this article will walk through what the current market price might be implying about its value. The stock last closed at US$226.10, with a 1 year return of 73.0% and a 3 year return of 94.7%, alongside a recent 7 day return showing a 3.9% decline and a 30 day and year to date return of 6.0%. Recent attention on Ascendis Pharma has been shaped by company specific developments and sector news that...
NasdaqGS:VLY
NasdaqGS:VLYBanks

Carlos Vazquez Joins Valley National Board Sharpening Risk And Capital Oversight

Valley National Bancorp (NasdaqGS:VLY) has appointed veteran banking executive Carlos Vazquez as an independent director. Vazquez brings decades of C suite and board experience at major financial institutions to Valley's board. He will serve on key committees focused on financial oversight, audit, and human capital governance. For you as an investor, this move sits squarely in the context of a regional bank sector that is under close scrutiny on risk management, funding stability, and board...
NasdaqCM:GEVO
NasdaqCM:GEVOOil and Gas

Assessing Gevo (GEVO) Valuation After CEO Succession Plan And Carbon Removal Progress

Leadership transition and carbon-removal update draw focus Gevo (GEVO) has attracted fresh attention after a special call outlining its planned CEO succession to President Paul Bloom in 2026 and providing updates on carbon-removal progress, including 500,000 credits from its North Dakota project. See our latest analysis for Gevo. Gevo’s recent leadership update and carbon removal progress come against a backdrop of softer share price momentum, with a 7 day share price return of 10.5% and a 90...
NYSE:LBRT
NYSE:LBRTEnergy Services

Is Liberty Energy (LBRT) Quietly Rewriting Its Story From Shale Services To Data Center Power?

Liberty Energy Inc. recently reported full-year 2025 results showing lower sales and earnings versus the prior year, while also affirming a US$0.09 per-share dividend payable in March 2026 and completing a US$479.36 million share repurchase program initiated in July 2022. At the same time, management outlined an ambitious push into distributed power for data centers, including long-term agreements that could materially reshape Liberty Energy’s business mix toward onsite power...
NYSE:GBX
NYSE:GBXMachinery

Assessing Greenbrier Companies (GBX) Valuation As Recent Momentum Meets Mixed Longer Term Returns

Why Greenbrier Companies (GBX) is on investors’ radar today Greenbrier Companies (GBX) has drawn fresh attention after recent share price moves, with the stock showing a mix of shorter term pullbacks and longer term gains across different time frames. Over the past day, the stock returned about 0.9%, while the past week was slightly negative. Over the past month and the past 3 months, returns were stronger, although the 1 year total return was a decline. See our latest analysis for Greenbrier...
NYSE:PJT
NYSE:PJTCapital Markets

PJT Partners Sees 2026 Secondaries Surge Shaping Capital Solutions Opportunity

PJT Partners (NYSE:PJT) has forecast continued robust growth in global secondaries market volume for 2026. The outlook follows what the firm describes as a record year for secondaries activity. PJT's global head of Capital Solutions outlined the view, highlighting potential large scale shifts in capital flows. PJT Partners, trading at $173.03, sits in the spotlight as the firm links its capital solutions franchise to a secondaries market it expects to stay busy into 2026. The stock has...
NasdaqGS:DVAX
NasdaqGS:DVAXBiotechs

Sanofi Buyout Of Dynavax Recasts Adult Vaccine Growth For Shareholders

Sanofi agreed to acquire Dynavax Technologies (NasdaqGS:DVAX) in a multi billion dollar deal. The transaction focuses on adding Dynavax's approved hepatitis B vaccine and its experimental shingles vaccine to Sanofi's adult vaccines portfolio. The deal is framed as an expansion of Sanofi's presence in adult immunizations. Dynavax Technologies, known for its vaccine work including its hepatitis B product, sits at the intersection of adult immunization and broader infectious disease...
NasdaqGS:DASH
NasdaqGS:DASHHospitality

Assessing DoorDash (DASH) Valuation After Recent Share Price Weakness And Profit Growth

DoorDash (DASH) shares have faced pressure recently, with the stock showing negative returns over the past month and past 3 months. This has prompted many investors to reassess what they are paying for the business today. See our latest analysis for DoorDash. Zooming out, DoorDash’s 30 day share price return of a 9.65% decline and 90 day share price return of a 19.56% decline contrast with its 1 year total shareholder return of 8.36%, hinting that recent momentum has faded compared with its...
NYSE:ESRT
NYSE:ESRTOffice REITs

Is Empire State Realty Trust (ESRT) Pricing Reflect Long-Term Prospects After Office And Tourism Shifts

If you are wondering whether Empire State Realty Trust's share price still reflects the value of its assets and income potential, looking closely at how the market currently prices the stock is a useful next step. The shares last closed at US$6.63, and over recent periods the stock saw a 1% decline over 7 days, a 1.7% gain over 30 days, a 2.5% gain year to date, but a 29.4% decline over 1 year and a 27.1% decline over 5 years. Recent price moves sit against an ongoing news flow around Empire...
NYSE:ACA
NYSE:ACAConstruction

Will Stronger Earnings And Upbeat Analyst Ratings Change Arcosa's (ACA) Narrative?

Recently, Barclays analyst Adam Seiden and TipRanks reiterated positive ratings on Arcosa following the company’s latest earnings release, which reported meaningful year-over-year revenue and net profit growth. This combination of upbeat analyst sentiment and improved financial performance has drawn fresh attention to how Arcosa is executing its business plan. We’ll now look at how Arcosa’s stronger earnings profile may influence the company’s investment narrative and longer-term appeal. AI...
NYSE:FTI
NYSE:FTIEnergy Services

Is It Too Late To Consider TechnipFMC (FTI) After Its 86% One-Year Rally?

If you are wondering whether TechnipFMC at around US$55.72 is still offering value or if most of the upside is already reflected in the price, you are asking the right question. The stock has delivered returns of 2.7% over the last 7 days, 25.0% over the last 30 days, 17.8% year to date and 86.5% over the last year, with a very large 3 year and 5 year return. This naturally raises questions about what you are paying for today. Recent coverage has focused on TechnipFMC's role in the energy...
NasdaqGS:HALO
NasdaqGS:HALOBiotechs

Is Halozyme Therapeutics (HALO) Still Attractive After Recent Drug Delivery Partnership-Driven Gains

Wondering whether Halozyme Therapeutics at US$71.71 still offers value, or if most of the opportunity is already priced in? This article walks through that question step by step. The stock shows returns of 3.6% over 7 days, 6.6% over 30 days, 2.0% year to date, 26.6% over 1 year, 36.2% over 3 years and 46.6% over 5 years, which naturally raises questions about how the current price lines up with its fundamentals. Recent news coverage around Halozyme has focused on its role in pharmaceutical...
NasdaqCM:NEGG
NasdaqCM:NEGGSpecialty Retail

A Look At Newegg Commerce (NEGG) Valuation After Chairman Detention And Governance Concerns

Newegg Commerce (NEGG) is back in focus after the company disclosed that chairman and controlling shareholder He Zhitao has been detained and placed under investigation, with multiple law firms now reviewing potential securities law issues. See our latest analysis for Newegg Commerce. The governance shock around the chairman’s detention comes after a sharp 41.6% decline in the 90 day share price return and a 10.8% fall over the last day, even though the 1 year total shareholder return remains...
NasdaqGS:NBIX
NasdaqGS:NBIXBiotechs

Neurocrine Biosciences (NBIX) Valuation Check After New Mid Stage VMAT2 Inhibitor Trial Update

Why this new trial matters for Neurocrine Biosciences (NBIX) shareholders Neurocrine Biosciences (NBIX) has kicked off a Phase 2 trial of NBI-1065890, a next generation VMAT2 inhibitor for tardive dyskinesia. This marks fresh pipeline activity that investors may watch closely. See our latest analysis for Neurocrine Biosciences. The Phase 2 trial news lands at a time when the share price, at US$136.06, has seen a 30 day share price return of 4.07% decline and a 1 year total shareholder return...
NYSE:SPH
NYSE:SPHGas Utilities

Suburban Propane Elevates Dagan To Guide Renewables And Long Term Growth

Suburban Propane Partners (NYSE:SPH) has created a new Senior Vice President, Renewable Energy role. M. Douglas Dagan has been promoted to fill this position, with responsibility for the partnership's renewable energy efforts. Suburban Propane Partners, trading at around $20.17, is best known for its propane distribution business, and its recent returns show meaningful longer term share price movement. The units are up 3.8% over the past week, 8.8% over the past 30 days, 7.9% year to date,...
NYSE:VZ
NYSE:VZTelecom

Verizon Communications (VZ) Margin Surge To 14.4% Tests Bearish Profitability Narratives

Verizon Communications (VZ) just posted its FY 2025 third quarter numbers, with revenue at US$33.8b, basic EPS of US$1.17 and net income excluding extra items of US$4.9b. The company has seen quarterly revenue move from US$33.3b in Q3 2024 to US$33.8b in Q3 2025, while basic EPS over the same quarters went from US$0.78 to US$1.17. This gives investors a clear read on how the top line and EPS have tracked over the past year. With trailing 12 month net profit margin reported at 14.4% versus...
NYSE:AS
NYSE:ASLuxury

How Investors May Respond To Amer Sports (AS) Early Partial Redemption Of 6.750% Senior Notes

Amer Sports, Inc. recently announced it will redeem US$80,000,000 of its 6.750% Senior Secured Notes due 2031 on February 6, 2026, at 103.000% of principal plus accrued interest. This partial early redemption, alongside the scheduled February 24, 2026 release of fourth quarter and fiscal 2025 results, highlights management’s current focus on balance sheet structure and financial communication. Next, we’ll examine how this early debt redemption shapes Amer Sports’ investment narrative and...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

Why Sandisk (SNDK) Is Up 21.6% After AI-Driven Beat And Extended Kioxia Capacity Pact

In late January 2026, Sandisk reported past second-quarter results showing sharply higher sales and profits and issued upbeat third-quarter revenue guidance, citing intense AI-driven demand for its NAND flash and enterprise SSD products. On the same day, Kioxia Corporation and Sandisk announced they had extended their long-running Yokkaichi and Kitakami flash-memory joint venture agreements through 2034, with Sandisk committing US$1.17 billion in staged payments to secure long-term...